ORIENTBIO Inc. - Asset Resilience Ratio

Latest as of December 2025: 32.60%

ORIENTBIO Inc. (002630) has an Asset Resilience Ratio of 32.60% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 002630 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩26.20 Billion

≈ $17.76 Million USD Cash + Short-term Investments

Total Assets

₩80.37 Billion

≈ $54.47 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how ORIENTBIO Inc.'s Asset Resilience Ratio has changed over time. See how leveraged is ORIENTBIO Inc.'s balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down ORIENTBIO Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002630 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩26.20 Billion	32.6%
Total Liquid Assets	₩26.20 Billion	32.60%

Asset Resilience Insights

Very High Liquidity: ORIENTBIO Inc. maintains exceptional liquid asset reserves at 32.60% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ORIENTBIO Inc. Industry Peers by Asset Resilience Ratio

Compare ORIENTBIO Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for ORIENTBIO Inc. (2006–2025)

The table below shows the annual Asset Resilience Ratio data for ORIENTBIO Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	30.67%	₩26.00 Billion ≈ $17.62 Million	₩84.78 Billion ≈ $57.46 Million	-5.54pp
2024-03-31	36.21%	₩35.12 Billion ≈ $23.80 Million	₩96.99 Billion ≈ $65.73 Million	-0.23pp
2023-03-31	36.44%	₩29.53 Billion ≈ $20.01 Million	₩81.05 Billion ≈ $54.93 Million	+8.76pp
2022-03-31	27.68%	₩29.05 Billion ≈ $19.69 Million	₩104.95 Billion ≈ $71.12 Million	+26.56pp
2021-03-31	1.12%	₩800.00 Million ≈ $542.15K	₩71.52 Billion ≈ $48.47 Million	+0.01pp
2020-03-31	1.11%	₩801.00 Million ≈ $542.83K	₩72.11 Billion ≈ $48.86 Million	+0.04pp
2019-03-31	1.07%	₩901.53 Million ≈ $610.96K	₩84.09 Billion ≈ $56.99 Million	-5.57pp
2018-03-31	6.64%	₩12.62 Billion ≈ $8.55 Million	₩190.03 Billion ≈ $128.78 Million	+5.47pp
2017-03-31	1.17%	₩2.02 Billion ≈ $1.37 Million	₩172.63 Billion ≈ $116.99 Million	+0.45pp
2016-03-31	0.72%	₩1.27 Billion ≈ $862.71K	₩175.64 Billion ≈ $119.03 Million	-3.44pp
2015-03-31	4.16%	₩6.19 Billion ≈ $4.20 Million	₩148.76 Billion ≈ $100.82 Million	-4.13pp
2014-03-31	8.30%	₩11.58 Billion ≈ $7.85 Million	₩139.63 Billion ≈ $94.63 Million	-0.80pp
2013-03-31	9.10%	₩12.39 Billion ≈ $8.40 Million	₩136.24 Billion ≈ $92.33 Million	-6.51pp
2012-03-31	15.61%	₩19.29 Billion ≈ $13.07 Million	₩123.55 Billion ≈ $83.73 Million	-3.39pp
2011-03-31	19.00%	₩16.12 Billion ≈ $10.92 Million	₩84.86 Billion ≈ $57.51 Million	+4.22pp
2010-03-31	14.77%	₩15.41 Billion ≈ $10.44 Million	₩104.31 Billion ≈ $70.69 Million	+0.69pp
2009-03-31	14.08%	₩13.82 Billion ≈ $9.37 Million	₩98.18 Billion ≈ $66.53 Million	-1.31pp
2008-03-31	15.39%	₩12.73 Billion ≈ $8.63 Million	₩82.72 Billion ≈ $56.06 Million	+10.26pp
2007-03-31	5.13%	₩3.74 Billion ≈ $2.53 Million	₩72.88 Billion ≈ $49.39 Million	-13.29pp
2006-03-31	18.42%	₩12.56 Billion ≈ $8.51 Million	₩68.17 Billion ≈ $46.20 Million	--

pp = percentage points

About ORIENTBIO Inc.

KO:002630 Korea Biotechnology

Market Cap

$72.49 Million

₩106.96 Billion KRW

Market Cap Rank

#20554 Global

#1124 in Korea

Share Price

₩902.00

Change (1 day)

-4.04%

52-Week Range

₩467.00 - ₩996.00

All Time High

₩6770.89